Elodia Di Renzo

Title: Elodia Di Renzo: Innovator in Pharmaceutical Development

Introduction

Elodia Di Renzo is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative methods for preparing pharmaceutical products. Her work is characterized by a commitment to enhancing the efficiency and effectiveness of drug formulation.

Latest Patents

Elodia holds a patent for a method of preparing a pharmaceutical product. This method involves several critical steps, including providing a neat active pharmaceutical ingredient (API) that meets specific parameters determined by a FT4 powder rheometer. The parameters include a specific basic flow energy of at most 60 mJ/g, a stability index of 0.75 to 1.25, and various other criteria that ensure the quality and performance of the pharmaceutical product. The process culminates in encapsulating the API within a pharmaceutical carrier, thereby producing a final product that meets rigorous standards.

Career Highlights

Elodia is currently employed at Novartis AG, a leading global healthcare company. Her role at Novartis allows her to leverage her expertise in pharmaceutical development and contribute to the advancement of innovative therapies. With her extensive knowledge and experience, she plays a vital role in the research and development of new pharmaceutical solutions.

Collaborations

Elodia has collaborated with notable colleagues, including David Hook and Markus Krumme. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their work in the pharmaceutical sector.

Conclusion

Elodia Di Renzo is a trailblazer in the pharmaceutical industry, with a focus on innovative methods for drug preparation. Her contributions not only reflect her dedication to advancing pharmaceutical science but also highlight the importance of collaboration in achieving groundbreaking results.